Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06934135Not ApplicableCompleted

Trial of Transcranial Photobiomodulation for Depression With PET and EEG Outcomes

Role: collaborator

NCT06054269Phase 3Active Not Recruiting

Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

Role: collaborator

NCT05435820Not ApplicableUnknown

Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With Laser

Role: lead

NCT02102009Not ApplicableCompleted

Nutritional Supplementation in Adults With Chronic Respiratory Disease

Role: collaborator

NCT02128984Not ApplicableCompleted

Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children

Role: collaborator

All 5 trials loaded